Biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer.

Sectors
Healthcare
Life Sciences
First Invested
2009
Public/PIPES
Company Status
IPO/Acquired
NASDAQ: SGEN
Acquired by Pfizer
Associated Team
Paul Walker